Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Telemedicine Evaluations for Low-Acuity Patients Presenting to the Emergency Department: Implications for Safety and Patient Satisfaction.

Hsu H, Greenwald PW, Clark S, Gogia K, Laghezza MR, Hafeez B, Sharma R.

Telemed J E Health. 2020 Jan 13. doi: 10.1089/tmj.2019.0193. [Epub ahead of print]

PMID:
31930952
2.

Antibiotic Prescribing Practices: Is There a Difference Between Patients Seen by Telemedicine Versus Those Seen In-Person?

Yao P, Clark S, Gogia K, Hafeez B, Hsu H, Greenwald P.

Telemed J E Health. 2020 Jan;26(1):107-109. doi: 10.1089/tmj.2018.0250. Epub 2019 Feb 14.

PMID:
30762493
3.

A Novel Emergency Department-Based Telemedicine Program: How Do Older Patients Fare?

Greenwald PW, Stern M, Clark S, Hafeez B, Gogia K, Hsu H, Mulcare M, Sharma R.

Telemed J E Health. 2019 Oct;25(10):966-972. doi: 10.1089/tmj.2018.0162. Epub 2018 Oct 24.

PMID:
30358524
4.

Use of Physician-Guided Patient Self-Examination to Diagnose Appendicitis: A Telemedicine Case Report.

Nachum S, Stern ME, Greenwald PW, Sharma R.

Telemed J E Health. 2019 Aug;25(8):769-771. doi: 10.1089/tmj.2018.0115. Epub 2018 Sep 7.

PMID:
30192203
5.

Planning for Future Disasters: Telemedicine as a Resource.

Greenwald PW, Hsu H, Sharma R.

Ann Emerg Med. 2018 Mar;71(3):435-436. doi: 10.1016/j.annemergmed.2017.10.031. No abstract available.

PMID:
29458811
6.

Older adults and technology: in telehealth, they may not be who you think they are.

Greenwald P, Stern ME, Clark S, Sharma R.

Int J Emerg Med. 2018 Jan 3;11(1):2. doi: 10.1186/s12245-017-0162-7.

7.

Increasing frequency and fatality of poison control center reported exposures involving medication and multiple substances: data from reports of the American Association of Poison Control Centers 1984-2013.

Greenwald PW, Farmer BM, O'Neill M, Essner RA, Flomenbaum NE.

Clin Toxicol (Phila). 2016 Aug;54(7):590-6. doi: 10.1080/15563650.2016.1183777. Epub 2016 May 23.

PMID:
27214065
8.

The ED as the primary source of hospital admission for older (but not younger) adults.

Greenwald PW, Estevez RM, Clark S, Stern ME, Rosen T, Flomenbaum N.

Am J Emerg Med. 2016 Jun;34(6):943-7. doi: 10.1016/j.ajem.2015.05.041. Epub 2015 May 30.

PMID:
27037128
9.

The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.

Gohagan JK, Prorok PC, Greenwald P, Kramer BS.

Rev Recent Clin Trials. 2015;10(3):173-80. Review.

PMID:
26238115
10.

John A. Milner: in memoriam (1947-2013).

Greenwald P, Stoner G, Colburn N, Lippman SM.

Cancer Prev Res (Phila). 2014 Apr;7(4):373-4. doi: 10.1158/1940-6207.CAPR-14-0060. No abstract available.

11.

Trends in short-stay hospitalizations for older adults from 1990 to 2010: implications for geriatric emergency care.

Greenwald PW, Stern ME, Rosen T, Clark S, Flomenbaum N.

Am J Emerg Med. 2014 Apr;32(4):311-4. doi: 10.1016/j.ajem.2013.12.011. Epub 2013 Dec 11.

PMID:
24512885
12.

A novel comprehensive in-training examination course can improve residency-wide scores.

Sharma R, Sperling JD, Greenwald PW, Carter WA.

J Grad Med Educ. 2012 Sep;4(3):378-80. doi: 10.4300/JGME-D-11-00154.1.

13.

Future directions in cancer prevention.

Umar A, Dunn BK, Greenwald P.

Nat Rev Cancer. 2012 Dec;12(12):835-48. doi: 10.1038/nrc3397. Epub 2012 Nov 15. Review.

PMID:
23151603
14.

Improving front-end flow in an urban academic medical center emergency department: the emergency department discharge facilitator team.

Sharma R, Mulcare MR, Graetz R, Greenwald PW, Mustalish AC, Miluszusky B, Flomenbaum NE.

J Urban Health. 2013 Jun;90(3):406-11. doi: 10.1007/s11524-012-9752-0.

15.

Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities.

Dunn BK, Jegalian K, Greenwald P.

Recent Results Cancer Res. 2011;188:21-47. doi: 10.1007/978-3-642-10858-7_3. Review.

PMID:
21253787
16.

Injury and illness in college outdoor education.

Gaudio FG, Greenwald PW, Holton M.

Wilderness Environ Med. 2010 Dec;21(4):363-70. doi: 10.1016/j.wem.2010.08.001.

PMID:
21168793
17.

Cancer Prevention II: Introduction.

Dunn BK, Greenwald P.

Semin Oncol. 2010 Aug;37(4):321-6. doi: 10.1053/j.seminoncol.2010.06.016. No abstract available.

PMID:
20816502
18.

Molecular markers for early detection.

Dunn BK, Wagner PD, Anderson D, Greenwald P.

Semin Oncol. 2010 Jun;37(3):224-42. doi: 10.1053/j.seminoncol.2010.05.007. Review.

PMID:
20709207
19.

Cancer prevention I: introduction.

Dunn BK, Greenwald P.

Semin Oncol. 2010 Jun;37(3):190-201. doi: 10.1053/j.seminoncol.2010.06.011. No abstract available.

PMID:
20709204
20.

Alarming colorectal cancer incidence trends: a case for early detection and prevention.

Umar A, Greenwald P.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1672-3. doi: 10.1158/1055-9965.EPI-09-0320. No abstract available.

21.

Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients.

Fatima N, Chelius D, Luke BT, Yi M, Zhang T, Stauffer S, Stephens R, Lynch P, Miller K, Guszczynski T, Boring D, Greenwald P, Ali IU.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):41-9.

22.

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M.

Lancet Oncol. 2009 May;10(5):501-7. doi: 10.1016/S1470-2045(09)70035-X. Review.

23.

Landmarks in the history of cancer epidemiology.

Greenwald P, Dunn BK.

Cancer Res. 2009 Mar 15;69(6):2151-62. doi: 10.1158/0008-5472.CAN-09-0416. Epub 2009 Mar 10. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

24.

Do we make optimal use of the potential of cancer prevention?

Greenwald P, Dunn BK.

Recent Results Cancer Res. 2009;181:3-17. Review.

PMID:
19213552
25.

Clinical significance of brush allodynia in emergency patients with migraine.

Friedman B, Bijur P, Greenwald P, Lipton R, Gallagher EJ.

Headache. 2009 Jan;49(1):31-5. doi: 10.1111/j.1526-4610.2008.01266.x.

PMID:
19125875
26.

Resident experience of abuse and harassment in emergency medicine: ten years later.

Li SF, Grant K, Bhoj T, Lent G, Garrick JF, Greenwald P, Haber M, Singh M, Prodany K, Sanchez L, Dickman E, Spencer J, Perera T, Cowan E.

J Emerg Med. 2010 Feb;38(2):248-52. doi: 10.1016/j.jemermed.2008.05.005. Epub 2008 Nov 20.

PMID:
19022605
27.

Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib.

Fatima N, Yi M, Ajaz S, Stephens RM, Stauffer S, Greenwald P, Munroe DJ, Ali IU.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3051-61. doi: 10.1158/1055-9965.EPI-08-0261. Epub 2008 Oct 28.

28.

A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine.

Friedman BW, Esses D, Solorzano C, Dua N, Greenwald P, Radulescu R, Chang E, Hochberg M, Campbell C, Aghera A, Valentin T, Paternoster J, Bijur P, Lipton RB, Gallagher EJ.

Ann Emerg Med. 2008 Oct;52(4):399-406. Epub 2007 Nov 19.

PMID:
18006188
30.

Randomized trial of IV dexamethasone for acute migraine in the emergency department.

Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, Corbo J, Chu J, Chew E, Cheung P, Fearon S, Paternoster J, Baccellieri A, Clark S, Bijur PE, Lipton RB, Gallagher EJ.

Neurology. 2007 Nov 27;69(22):2038-44. Epub 2007 Oct 17.

PMID:
17942818
31.

A favorable view: progress in cancer prevention and screening.

Greenwald P.

Recent Results Cancer Res. 2007;174:3-17. Review.

PMID:
17302181
32.

Clinical trials of vitamin and mineral supplements for cancer prevention.

Greenwald P, Anderson D, Nelson SA, Taylor PR.

Am J Clin Nutr. 2007 Jan;85(1):314S-317S. Review.

PMID:
17209217
33.

Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells.

Lou J, Fatima N, Xiao Z, Stauffer S, Smythers G, Greenwald P, Ali IU.

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1598-606.

34.

Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.

Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman SM, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1479-84.

35.

Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.

Ali IU, Xiao Z, Malone W, Smith M, Conrads TP, Veenstra TD, Greenwald P, Luke BT, McLarty JW.

Oncol Rep. 2006 May;15(5):1367-72.

PMID:
16596212
36.

The future of cancer prevention.

Greenwald P.

Semin Oncol Nurs. 2005 Nov;21(4):296-8. Review.

PMID:
16293518
37.
38.

Low-dose naloxone does not improve morphine-induced nausea, vomiting, or pruritus.

Greenwald PW, Provataris J, Coffey J, Bijur P, Gallagher EJ.

Am J Emerg Med. 2005 Jan;23(1):35-9.

PMID:
15672335
39.

Lifestyle and medical approaches to cancer prevention.

Greenwald P.

Recent Results Cancer Res. 2005;166:1-15. Review.

PMID:
15648179
40.

Nutritional interventions in cancer prevention.

Taylor PR, Greenwald P.

J Clin Oncol. 2005 Jan 10;23(2):333-45. Review.

PMID:
15637396
41.

Clinical trials in cancer prevention: current results and perspectives for the future.

Greenwald P.

J Nutr. 2004 Dec;134(12 Suppl):3507S-3512S. doi: 10.1093/jn/134.12.3507S. Review.

PMID:
15570061
42.

Nutrition and physical activity and chronic disease prevention: research strategies and recommendations.

Prentice RL, Willett WC, Greenwald P, Alberts D, Bernstein L, Boyd NF, Byers T, Clinton SK, Fraser G, Freedman L, Hunter D, Kipnis V, Kolonel LN, Kristal BS, Kristal A, Lampe JW, McTiernan A, Milner J, Patterson RE, Potter JD, Riboli E, Schatzkin A, Yates A, Yetley E.

J Natl Cancer Inst. 2004 Sep 1;96(17):1276-87. Review.

PMID:
15339966
43.

Emergency department visits for home medical device failure during the 2003 North America blackout.

Greenwald PW, Rutherford AF, Green RA, Giglio J.

Acad Emerg Med. 2004 Jul;11(7):786-9.

44.

Preface. The applications of bioinformatics in cancer detection.

Greenwald P.

Ann N Y Acad Sci. 2004 May;1020:ix-x. No abstract available.

PMID:
15212042
45.

Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.

Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU.

Cancer Res. 2004 Apr 15;64(8):2904-9.

46.

Cancer risk and diet in India.

Sinha R, Anderson DE, McDonald SS, Greenwald P.

J Postgrad Med. 2003 Jul-Sep;49(3):222-8. Review.

47.

The antioxidant conundrum in cancer.

Seifried HE, McDonald SS, Anderson DE, Greenwald P, Milner JA.

Cancer Res. 2003 Aug 1;63(15):4295-8. Review.

48.

An evidence-based approach to cancer prevention clinical trials.

Greenwald P, McDonald SS, Anderson DE.

Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S43-7. Review.

PMID:
12570334
49.

How distracting is distracting pain?

Li SF, Greenwald PW.

Am J Emerg Med. 2003 Jan;21(1):43-4.

PMID:
12563579
50.

Micronutrients in cancer chemoprevention.

Greenwald P, Milner JA, Anderson DE, McDonald SS.

Cancer Metastasis Rev. 2002;21(3-4):217-30. Review.

PMID:
12549762

Supplemental Content

Loading ...
Support Center